We develop custom cancer models for your drug and indication

Understand resistance at any stage

Target Selection
Pathway Identification
Combination Selection
Candidate Screening
Candidate Optimization
Pipeline Prioritization
Resistance Biomarker Identification
Resistance Informed Trial Design
In-Licensing Analysis
Indication Expansion
Optimizing Market Capture

Unlock the power of collaboration
Experience the difference when partnering with us

Direct cross indication or therapeutic comparisons

Detailed genomic, transcriptomic, proteomic, and pathway insights.

Collaborate with us to overcome resistance